Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02977468Phase 1Completed
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Triple Negative Breast Cancer
PrincipalinvestigatorStart date: 2017-10-25
NCT03165487Completed
Comparison of the Breast Tumor Microenvironment
Hormone Receptor Positive Malignant Neoplasm of BreastTriple Negative Breast Cancer
PrincipalinvestigatorStart date: 2017-09-28
NCT03216421Not ApplicableActive Not Recruiting
Intraoperative Radiation Therapy (IORT) in DCIS
Breast CancerDuctal Carcinoma in Situ
PrincipalinvestigatorStart date: 2017-09-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Assistant Professor of Radiation Oncology
Assistant Professor Of Radiation Oncology

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02977468Phase 1PrincipalInvestigator

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

Triple Negative Breast Cancer
Completed
NCT03165487PrincipalInvestigator

Comparison of the Breast Tumor Microenvironment

Hormone Receptor Positive Malignant Neoplasm of BreastTriple Negative Breast Cancer
Completed
NCT03216421Not ApplicablePrincipalInvestigator

Intraoperative Radiation Therapy (IORT) in DCIS

Breast CancerDuctal Carcinoma in Situ
Active Not Recruiting

All 3 trials loaded